ADK
Basic information
Region (hg38): 10:74151202-74709963
Links
Phenotypes
GenCC
Source:
- adenosine kinase deficiency (Strong), mode of inheritance: AR
- adenosine kinase deficiency (Supportive), mode of inheritance: AR
- adenosine kinase deficiency (Definitive), mode of inheritance: AR
- adenosine kinase deficiency (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hypermethioninemia due to adenosine kinase deficiency | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Audiologic/Otolaryngologic; Biochemical; Cardiovascular; Gastrointestinal; Neurologic | 21963049 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (89 variants)
- Adenosine_kinase_deficiency (38 variants)
- Inborn_genetic_diseases (28 variants)
- ADK-related_disorder (5 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADK gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006721.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 22 | 26 | ||||
missense | 48 | 53 | ||||
nonsense | 1 | |||||
start loss | 2 | 2 | ||||
frameshift | 7 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 5 | 10 | 50 | 22 | 2 |
Highest pathogenic variant AF is 0.00000572496
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ADK | protein_coding | protein_coding | ENST00000286621 | 11 | 558102 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000313 | 0.988 | 125720 | 0 | 20 | 125740 | 0.0000795 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.50 | 129 | 187 | 0.690 | 0.00000878 | 2404 |
Missense in Polyphen | 28 | 61.495 | 0.45532 | 768 | ||
Synonymous | 0.800 | 56 | 64.2 | 0.873 | 0.00000313 | 654 |
Loss of Function | 2.23 | 9 | 19.7 | 0.457 | 9.14e-7 | 252 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000150 | 0.000149 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: ATP dependent phosphorylation of adenosine and other related nucleoside analogs to monophosphate derivatives. Serves as a potential regulator of concentrations of extracellular adenosine and intracellular adenine nucleotides.;
- Pathway
- Purine metabolism - Homo sapiens (human);Abacavir Pathway, Pharmacokinetics/Pharmacodynamics;Thiopurine Pathway, Pharmacokinetics/Pharmacodynamics;Mercaptopurine Action Pathway;Azathioprine Action Pathway;Thioguanine Action Pathway;Mercaptopurine Metabolism Pathway;Metabolism of nucleotides;Metabolism;Nucleotide salvage;Purine salvage;Purine nucleotides nucleosides metabolism;superpathway of purine nucleotide salvage;adenine and adenosine salvage II
(Consensus)
Recessive Scores
- pRec
- 0.686
Intolerance Scores
- loftool
- 0.427
- rvis_EVS
- -0.34
- rvis_percentile_EVS
- 30.07
Haploinsufficiency Scores
- pHI
- 0.223
- hipred
- Y
- hipred_score
- 0.613
- ghis
- 0.646
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.532
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Adk
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; respiratory system phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- purine ribonucleoside salvage;dATP biosynthetic process;ribonucleoside monophosphate biosynthetic process;phosphorylation;purine-containing compound salvage;AMP salvage
- Cellular component
- nucleus;nucleoplasm;cytosol
- Molecular function
- RNA binding;adenosine kinase activity;ATP binding;metal ion binding